![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Pentapharm Ag Aesch Ch, based in Switzerland, is a pharmaceutical company.
One of their significant offerings is Aprotinin concentrated solution, Activity: 100 - 136 Ph. Eur. Units of aprotinin activity per mL Bacterial endotoxin free, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2002-095 - Rev 06
This Chemical and TSE Type CEP, issued on June 30, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 579 associated with this CEP further emphasizes